Research Article

A Heterocyclic Compound Hispidulin: Theoretical Investigation by DFT/TD-DFT Methods and Molecular Docking Studies

Volume: 26 Number: 3 December 20, 2022
EN TR

A Heterocyclic Compound Hispidulin: Theoretical Investigation by DFT/TD-DFT Methods and Molecular Docking Studies

Abstract

Flavonoids are polyphenolic plant secondary metabolites with biological properties including Alzheimer's disease (AD) inhibition activities. Numerous studies have been conducted on naturally occurring flavonoids modified to obtain effective drugs for the management of AD. In this study, DFT/B3PW91, TD-DFT/B3LYP methods of target molecule hispidulin 4′,5,7-Trihydroxy-6-Methoxyflavone (THMF) and LANL2DZ (d,p), 6-311G (d,p) basic HOMO-LUMO energy calculations, optimized molecular geometry, molecular electrostatic potential surface (MEPS), non-linear optics (NLO), charge transfer within the molecule and mulliken atomic charges structure were determined and the results were displayed. Moreover the identification of the mechanism of action of the tested compound based on the structure-activity relationship with the molecular docking process is to provide important information to be considered for further research, and thus to design new, more efficient and selective systems.

Keywords

References

  1. [1] Brookmeyer, R., Johnson, E., Ziegler-Graham, K., Arrighi, H. M. 2007. Forecasting the global burden of Alzheimer’s disease. Alzheimer's & dementia, 3(3), 186-191.
  2. [2] Karantzoulis, S., Galvin, J. E. 2011. Distinguishing Alzheimer’s disease from other major forms of dementia. Expert review of neurotherapeutics, 11(11), 1579-1591.
  3. [3] Ozturk, O., Farouk, F. M., Ooi, L., Law, C. S. W., Muhammed, M. T., Aki-Yalcin, E., Yeong, K. Y. 2022. Synthesis of novel carboxamide-and carbohydrazide-benzimidazoles as selective butyrylcholinesterase inhibitors. Molecular Diversity, 26(5), 2863-2876.
  4. [4] Phosrithong, N., Samee, W., Nunthanavanit, P., Ungwitayatorn, J. 2012. In vitro antioxidant activity study of novel chromone derivatives. Chemical Biology & Drug Design, 79(6), 981-989.
  5. [5] Jalili-Baleh, L., Babaei, E., Abdpour, S., Bukhari, S. N. A., Foroumadi, A., Ramazani, A., Khoobi, M. 2018. A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease. European journal of medicinal chemistry, 152, 570-589.
  6. [6] Berk, Ş., Kaya, S., Akkol, E. K., Bardakçı, H. 2022. A comprehensive and current review on the role of flavonoids in lung cancer: experimental and theoretical approaches. Phytomedicine, 153938.
  7. [7] Zagal, J. H., Griveau, S,. Silva, J. F., Nyokong, T., Bedioui, F. 2010. Metallophthalocyanine-based molecular materials as catalysts for electrochemical reactions. Coordination Chemistry Reviews, 254(23-24), 2755-2791.
  8. [8] Urbani, M., de la Torre, G., Nazeeruddin, M. K., Torres, T. 2019. Phthalocyanines and porphyrinoid analogues as hole-and electron-transporting materials for perovskite solar cells. Chemical Society Reviews, 48(10), 2738-2766.

Details

Primary Language

English

Subjects

Engineering

Journal Section

Research Article

Publication Date

December 20, 2022

Submission Date

June 4, 2022

Acceptance Date

October 9, 2022

Published in Issue

Year 2022 Volume: 26 Number: 3

APA
Ata, A. Ç., Tanrıverdi, A. A., Yıldıko, Ü., & Çakmak, İ. (2022). A Heterocyclic Compound Hispidulin: Theoretical Investigation by DFT/TD-DFT Methods and Molecular Docking Studies. Süleyman Demirel Üniversitesi Fen Bilimleri Enstitüsü Dergisi, 26(3), 515-522. https://doi.org/10.19113/sdufenbed.1126132
AMA
1.Ata AÇ, Tanrıverdi AA, Yıldıko Ü, Çakmak İ. A Heterocyclic Compound Hispidulin: Theoretical Investigation by DFT/TD-DFT Methods and Molecular Docking Studies. J. Nat. Appl. Sci. 2022;26(3):515-522. doi:10.19113/sdufenbed.1126132
Chicago
Ata, Ahmet Çağrı, Aslıhan Aycan Tanrıverdi, Ümit Yıldıko, and İsmail Çakmak. 2022. “A Heterocyclic Compound Hispidulin: Theoretical Investigation by DFT TD-DFT Methods and Molecular Docking Studies”. Süleyman Demirel Üniversitesi Fen Bilimleri Enstitüsü Dergisi 26 (3): 515-22. https://doi.org/10.19113/sdufenbed.1126132.
EndNote
Ata AÇ, Tanrıverdi AA, Yıldıko Ü, Çakmak İ (December 1, 2022) A Heterocyclic Compound Hispidulin: Theoretical Investigation by DFT/TD-DFT Methods and Molecular Docking Studies. Süleyman Demirel Üniversitesi Fen Bilimleri Enstitüsü Dergisi 26 3 515–522.
IEEE
[1]A. Ç. Ata, A. A. Tanrıverdi, Ü. Yıldıko, and İ. Çakmak, “A Heterocyclic Compound Hispidulin: Theoretical Investigation by DFT/TD-DFT Methods and Molecular Docking Studies”, J. Nat. Appl. Sci., vol. 26, no. 3, pp. 515–522, Dec. 2022, doi: 10.19113/sdufenbed.1126132.
ISNAD
Ata, Ahmet Çağrı - Tanrıverdi, Aslıhan Aycan - Yıldıko, Ümit - Çakmak, İsmail. “A Heterocyclic Compound Hispidulin: Theoretical Investigation by DFT TD-DFT Methods and Molecular Docking Studies”. Süleyman Demirel Üniversitesi Fen Bilimleri Enstitüsü Dergisi 26/3 (December 1, 2022): 515-522. https://doi.org/10.19113/sdufenbed.1126132.
JAMA
1.Ata AÇ, Tanrıverdi AA, Yıldıko Ü, Çakmak İ. A Heterocyclic Compound Hispidulin: Theoretical Investigation by DFT/TD-DFT Methods and Molecular Docking Studies. J. Nat. Appl. Sci. 2022;26:515–522.
MLA
Ata, Ahmet Çağrı, et al. “A Heterocyclic Compound Hispidulin: Theoretical Investigation by DFT TD-DFT Methods and Molecular Docking Studies”. Süleyman Demirel Üniversitesi Fen Bilimleri Enstitüsü Dergisi, vol. 26, no. 3, Dec. 2022, pp. 515-22, doi:10.19113/sdufenbed.1126132.
Vancouver
1.Ahmet Çağrı Ata, Aslıhan Aycan Tanrıverdi, Ümit Yıldıko, İsmail Çakmak. A Heterocyclic Compound Hispidulin: Theoretical Investigation by DFT/TD-DFT Methods and Molecular Docking Studies. J. Nat. Appl. Sci. 2022 Dec. 1;26(3):515-22. doi:10.19113/sdufenbed.1126132

Cited By

e-ISSN :1308-6529
Linking ISSN (ISSN-L): 1300-7688

All published articles in the journal can be accessed free of charge and are open access under the Creative Commons CC BY-NC (Attribution-NonCommercial) license. All authors and other journal users are deemed to have accepted this situation. Click here to access detailed information about the CC BY-NC license.